Immunohistochemistry Market

F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US) and Agilent Technologies, Inc. (US) are the Key key Players in the Immunohistochemistry (IHC) Market

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period.

The global immunohistochemistry market is highly competitive. Prominent players operating in the global immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product launches and approvals to expand their product and geographic footprint and increase market presence.

To know about the assumptions considered for the study download the pdf brochure

F. Hoffmann-La Roche AG (Roche) is a global biotechnology company engaged in the development and manufacturing of pharmaceutical and diagnostic products. The company operates through two major divisions or segments, namely, Pharmaceuticals and Diagnostics. The Diagnostics division consists of the four business areas: Centralized and Point of Care Solutions, Molecular Diagnostics, Tissue Diagnostics, and Diabetes Care. The company provides a range of immunohistochemistry products through the Tissue Diagnostics segment. The company has a presence across Europe, the Middle East & Africa, North America, Asia Pacific, and Latin America.

Danaher Corporation is a global science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Diagnostics segment provides clinical instrumentation, test consumables, and software to healthcare professionals, and conducts its business through Core Lab Diagnostics, Molecular Diagnostics, Critical Care Diagnostics, and Anatomical Pathology Diagnostics segments. The company offers IHC products through Leica Biosystems, under the Anatomical Pathology Diagnostics and Core Lab Diagnostics segments. Products from these segments include chemical and immuno-staining instruments; reagents; antibodies; consumables; tissue embedding, processing, and slicing instruments; and related reagents and consumables. Slide cover-slipping and slide/cassette marking instruments and imaging instrumentation (including slide scanners) are offered by the company in the field of IHC. The company has its reach in about 60 countries and operates through 261 offices.

Agilent Technologies, Inc. is a leading player in life sciences, diagnostics, and applied chemical markets, providing application-focused solutions that include instruments, software, services, and consumables for the entire laboratory workflow in the fields of food, environmental and forensics, pharmaceutical, diagnostic, chemical & energy, and research. Agilent operates under three business segments—Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Diagnostics and Genomics segment is further segmented into six businesses: Genomics, Nucleic Acid Solutions, Pathology Solutions, Companion Diagnostics, Reagent Partnership, and Biomolecular Analysis. The company offers IHC products through the Pathology Solutions business, focused on cancer diagnostics and anatomic pathology workflows. The company has a presence across North America, Europe, and Asia Pacific. Major countries include the US, the UK, Australia, China, Germany, Italy, Malaysia, Singapore, Belgium, Denmark, Japan, and the Netherlands.

Related Reports:

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End user (Hospitals, Diangostic labs, Academia) - Global Forecast to 2026

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Immunohistochemistry Market Size,  Share & Growth Report
Report Code
BT 4780
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2023 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status